Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meeting
GlobeNewswire
*Welcomes Recent Announcement by Novavax of Licensing Agreement with Sanofi**Stresses Significant Value Still Remains to Be..